Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nedaplatin vs Cisplatin in locally advanced nasopharyngeal carcinoma
NCT04437329Phase 3Recruiting
- Sponsor
- Cancer Center of Guangzhou Medical University
- Start
- Aug 2020
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
A Phase 3 trial of nedaplatin in nasopharyngeal carcinoma (NPC), sponsored by Cancer Center of Guangzhou Medical University. Started Aug 2020; status: recruiting.
02
Drugs
nedaplatin
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT04437329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04437329.